Results 1 to 10 of about 162,800 (333)
Self-reported and actual beta-blocker prescribing for heart failure patients: physician predictors. [PDF]
PLoS ONE, 2009 Beta-blockers reduce mortality among patients with systolic heart failure (HF), yet primary care provider prescription rates remain low.To examine the association between primary care physician characteristics and both self-reported and actual ...
Sanjai Sinha +3 more
doaj +4 more sources
Beta-blockers and asthma. [PDF]
Heart, 1978 In a single-blind, randomised, crossover study in 10 asthmatic patients, the effects of approximately equipotent oral doses of 3 cardioselective beta-blockers-atenolol (100 mg), metoprolol (100 mg), and acebutolol (300 mg)-and 4 non-cardioselective beta-blockers-proranolol (100 mg), oxprenolol (100 mg), pindolol (5 mg), and timolol (10 mg) upon FEV1 ...
M K Benson +4 more
openaire +4 more sources
Beta Blockers and Melanoma [PDF]
Open Access Macedonian Journal of Medical Sciences, 2019 Understanding the mechanisms of cancer immune-tolerance is one of the most important challenges. Several studies have demonstrated the potential anticarcinogenic effects of beta-blockers, in patients with prostate cancer, breast cancer, and melanoma.
Petar Vojvodic +11 more
openaire +6 more sources
Current Knowledge of Beta-Blockers in Chronic Hemodialysis Patients [PDF]
International Journal of Nephrology and Renovascular Disease, 2023 Intissar Haddiya,1,2 Siria Valoti3 1Department of Nephrology, Faculty of Medicine and Pharmacy, University Mohamed Premier, Oujda, Morocco; 2Laboratory of Epidemiology, Clinical Research and Public Health, Faculty of Medicine and Pharmacy, University ...
Haddiya I, Valoti S
doaj +2 more sources
By inhibiting β-adrenergic receptors, beta-blockers lower blood pressure and heart rate and are used to treat cardiovascular illnesses such as hypertension, angina, arrhythmias, and heart failure. Variations in these medications' oral absorption, distribution, hepatic metabolism, and renal excretion impact their therapeutic utility.
Farzam K, Jan A.
europepmc +2 more sources
Beta-Blockers of Different Generations: Features of Influence on the Disturbances of Myocardial Energy Metabolism in Doxorubicin-Induced Chronic Heart Failure in Rats [PDF]
BiomedicinesBeta-blockers are first-line drugs in the treatment of chronic heart failure (CHF). However, there is no consensus on the specific effects of the beta-blockers of the I-III generation on energy metabolism in CHF.
Igor Belenichev +7 more
doaj +2 more sources
Beta-blockers and health-related quality of life in patients with peripheral arterial disease and COPD [PDF]
International Journal of COPD, 2009 Yvette RBM van Gestel1, Sanne E Hoeks1, Don D Sin2, Henk Stam3, Frans W Mertens3, Jeroen J Bax4, Ron T van Domburg5, Don Poldermans61Department of Anesthesiology, Erasmus Medical Center, Rotterdam, The Netherlands; 2Department of Medicine ...
Yvette RBM van Gestel +7 more
doaj +3 more sources
Frontiers in Pharmacology, 2021 Objectives: Rheumatoid arthritis (RA) is an independent nontraditional risk factor for incidence of myocardial infarction (MI) and post-MI outcome is impaired in the RA population.
Sheng-Fu Liu +14 more
doaj +1 more source
Neuropsychiatric Consequences of Lipophilic Beta-Blockers
Medicina, 2021 Beta-blockers are a class of drugs with important benefits in cardiovascular pathology. In this paper, we aim to highlight their adverse and therapeutic effects in the neuropsychiatric field.
Sabina Alexandra Cojocariu +5 more
doaj +1 more source